Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCP Infrastructure Investments Regulatory News (GCP)

Share Price Information for GCP Infrastructure Investments (GCP)

Share Price is delayed by 15 minutes
Get Live Data
77.90    -0.10 (-0.13%)
Bid:
77.80
Ask:
78.20
Spread: 0.40 (0.514%)
Market Cap: £629.69m
GCP Live PriceLast checked at - London Stock Exchange

Intraday GCP Infrastructure Investments Share Chart

Subscription for loan notes

26 Feb 2013 15:00

RNS Number : 7187Y
GCP Infrastructure Investments Ltd
26 February 2013
 



 

GCP Infrastructure Investments Ltd 26 February 2013

 

GCP Infrastructure Investments Limited

(the "Company")

c. £6.6 million Investment Completions

 

The Board of Directors of the Company is pleased to announce that on 22 and 26 February 2013 the Master Fund completed two transactions subscribing for loan notes with an aggregate value of c. £6.6 million (the "Notes"). Of this aggregate sum, c. £4.3 million is a fully-drawn loan secured on a subordinated basis against the cash flows arising from an operational accommodation PFI asset in England, while the remaining c. £2.3 million comprises a fully-drawn loan secured on a subordinated basis against an operational education PFI asset in Scotland.

The weighted average yield on the Notes is c.8.9 per cent. per annum on an annualised basis, with a weighted average expected life of c. 24 years.

The acquisition of the Notes has been financed fully from available cash reserves. 

Notes to Editors

The Company is a closed-ended investment company that seeks to generate returns from subordinated infrastructure debt and related and/or similar assets (the "Target Assets"). The Company achieves this by investing substantially all of its capital in GCP Infrastructure Fund Limited (the "Master Fund"), an open-ended investment company that holds the Target Assets. The Company is the majority shareholder of the Master Fund. The Company and the Master Fund are advised by Gravis Capital Partners LLP (the "Investment Adviser").

Contact details:

 

Gravis Capital Partners LLP

Stephen Ellis

+44 (0)20 7518 1495

 

Rollo Wright

+44 (0)20 7518 1493

 

 

Oriel Securities

Joe Winkley

+44 (0)20 7710 7600

 

Gareth Price

Neil Winward

 

Buchanan Communications

Charles Ryland/Sophie McNulty/Louise Hadcocks

+44 (0)20 7466 5000

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFESFFIRFIV
Date   Source Headline
6th Aug 20207:00 amRNSScrip Share Reference Price
30th Jul 20207:00 amRNSInvestor Report as at 30 June 2020
28th Jul 20201:19 pmRNSNotification of Major Holdings
23rd Jul 202010:42 amRNSDividend Declaration & Scrip Dividend Alternative
15th Jul 20207:00 amRNSNet Asset Value(s)
30th Jun 20207:00 amRNSTotal Voting Rights
10th Jun 20205:35 pmRNSDirector/PDMR Shareholding
10th Jun 202012:04 pmRNSAdditional Listing and Total Voting Rights
3rd Jun 20207:00 amRNSAdditional Listing
1st Jun 20201:48 pmRNSUpdate research from QuotedData
29th May 20207:00 amRNSHalf-yearly Report and Financial Statements 2020
15th May 20207:00 amRNSScrip Share Reference Price
1st May 20207:00 amRNSInvestor Report as at 31 March 2020
24th Apr 202011:16 amRNSDividend Declaration & Scrip Dividend Alternative
20th Apr 20207:00 amRNSNet Asset Value(s)
31st Mar 20207:00 amRNSTotal Voting Rights
20th Mar 20207:00 amRNSCovid-19 update
10th Mar 20204:53 pmRNSDirector/PDMR Shareholding
9th Mar 20209:23 amRNSAdditional Listing and Total Voting Rights
28th Feb 20207:00 amRNSAdditional Listing
13th Feb 20201:23 pmRNSResult of AGM and EGM
13th Feb 20201:00 pmRNSDirectorate Change
13th Feb 20207:00 amRNSScrip Share Reference Price
3rd Feb 20207:00 amRNSInvestor Report as at 31 December 2019
30th Jan 202010:52 amRNSInitiation research from QuotedData
24th Jan 202010:22 amRNSDividend Declaration & Scrip Dividend Alternative
15th Jan 20207:00 amRNSNet Asset Value(s)
3rd Jan 20207:00 amRNSNotice of AGM and EGM Circulars
12th Dec 201910:45 amRNSReplace - Annual report and financial statements
12th Dec 20197:00 amRNSAnnual report and financial statements
29th Nov 20197:00 amRNSTotal Voting Rights
26th Nov 20197:00 amRNSDirector/PDMR Shareholding
22nd Nov 20194:24 pmRNSDirector/PDMR Shareholding
22nd Nov 20199:22 amRNSAdditional Listing and Total Voting Rights
15th Nov 20197:00 amRNSAdditional Listing
4th Nov 20197:00 amRNSInvestor Report as at 30 September 2019
31st Oct 20197:00 amRNSScrip Share Reference Price
16th Oct 20193:54 pmRNSCommittee Changes
15th Oct 20197:00 amRNSDividend Declaration & Scrip Dividend Alternative
14th Oct 20197:00 amRNSNet Asset Value(s)
17th Sep 20197:00 amRNSDirector Composition Changes
30th Aug 20197:00 amRNSTotal Voting Rights
28th Aug 20192:01 pmRNSDirector/PDMR Shareholding
28th Aug 201910:58 amRNSDirector/PDMR Shareholding
27th Aug 201910:00 amRNSAdditional Listing and Total Voting Rights
22nd Aug 20197:00 amRNSAdditional Listing
6th Aug 20197:00 amRNSInvestor Report as at 28 June 2019
1st Aug 20197:00 amRNSScrip Share Reference Price
15th Jul 20197:00 amRNSNet Asset Value(s)
12th Jul 20192:42 pmRNSDividend Declaration & Scrip Dividend Alternative

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.